GVB Biopharma — Form D
GVB Biopharma of LAS VEGAS, NV, a company, filed a Form D exempt-offering notice with the SEC on 2022-01-19. The offering totals $1.8M, of which $1.8M was reported sold. Industry: Manufacturing.
Offering
- Filed: 2022-01-19
- Form: D
- Accession: 0001809889-22-000001
- Industry: Manufacturing
- Exemptions: 06b
- Total offering: $1.8M
- Amount sold: $1.8M
- Minimum investment: $50K
- Investors: 2
- Date of first sale: 2022-01-07
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-429877
Issuer
- Name: GVB Biopharma
- CIK: 0001809889
- Entity type: Corporation
- Jurisdiction: NEVADA
- Incorporated: 2019
- Address: 4456 E. CRAIG RD., LAS VEGAS, NV, 89115
- Phone: 2139261580
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Theodore Swindells | Director | Las Vegas, NV |
| William Spiegel | Director | Las Vegas, NV |
| William Spiegel | Executive Officer | Las Vegas, NV |
| Jack Feldman | Director | Las Vegas, NV |
| Jack Feldman | Executive Officer | Las Vegas, NV |
| Phillip Swindells | Director | Las Vegas, NV |
| Phillip Swindells | Executive Officer | Las Vegas, NV |
Other filings by this issuer (5)
More